Curcumin induces apoptosis of HepG2 cells via inhibiting fatty acid synthase (Q39131257)

9 September 2017

Curcumin induces apoptosis of HepG2 cells via inhibiting fatty acid synthase (English)

1 reference

9 September 2017

0 references

0 references

Huijin Fan

1

1 reference

PubMed ID

23821378

9 September 2017

Weixi Tian

series ordinal

2

1 reference

PubMed ID

23821378

9 September 2017

Xiaofeng Ma

series ordinal

3

1 reference

9 September 2017

3 July 2013

1 reference

9 September 2017

1 reference

9 September 2017

9

1 reference

9 September 2017

3

1 reference

9 September 2017

279-286

1 reference

https://scigraph.springernature.com/pub.10.1007/s11523-013-0286-5

9 September 2017

0 references

cites work

Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS11523-013-0286-5

De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-013-0286-5

Fatty acid synthase as a potential therapeutic target in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-013-0286-5

Increased expression of fatty acid synthase (OA-519) in ovarian neoplasms predicts shorter survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-013-0286-5

Biological characteristics and chemosensitivity profile of four human anaplastic thyroid carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-013-0286-5

Epigallocatechin-3-gallate is a potent natural inhibitor of fatty acid synthase in intact cells and selectively induces apoptosis in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-013-0286-5

Fatty acid metabolism in breast cancer cells: differential inhibitory effects of epigallocatechin gallate (EGCG) and C75.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-013-0286-5

Comparison of yield, composition, and antioxidant activity of turmeric (Curcuma longa L.) extracts obtained using various techniques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-013-0286-5

Combined inhibitory effects of curcumin and phenethyl isothiocyanate on the growth of human PC-3 prostate xenografts in immunodeficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-013-0286-5

Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-013-0286-5

Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-013-0286-5

Curcumin and cancer cells: how many ways can curry kill tumor cells selectively?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-013-0286-5

Curcumin inhibits tumor proliferation induced by neutrophil elastase through the upregulation of α1-antitrypsin in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-013-0286-5

Anti-tumour and antioxidant activity of natural curcuminoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-013-0286-5

Suppression of fatty acid synthase, differentiation and lipid accumulation in adipocytes by curcumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-013-0286-5

Green tea epigallocatechin gallate: a natural inhibitor of fatty-acid synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-013-0286-5

Molecular targets of dietary agents for prevention and therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-013-0286-5

Proto-oncogene FBI-1 (Pokemon) and SREBP-1 synergistically activate transcription of fatty-acid synthase gene (FASN).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-013-0286-5

Fatty acid synthase and cancer: new application of an old pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-013-0286-5

Induction of apoptosis in human lung cancer cells by curcumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-013-0286-5

Curcumin: from ancient medicine to current clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-013-0286-5

Curcumin decreases survival of Hep3B liver and MCF-7 breast cancer cells: the role of HIF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-013-0286-5

Molecular targets of curcumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-013-0286-5

Comparative studies on the suppression of nitric oxide synthase by curcumin and its hydrogenated metabolites through down-regulation of IkappaB kinase and NFkappaB activation in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-013-0286-5

Curcumin enhances the effects of 5-fluorouracil and oxaliplatin in mediating growth inhibition of colon cancer cells by modulating EGFR and IGF-1R.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-013-0286-5

Curcumin as "Curecumin": from kitchen to clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-013-0286-5

Fatty acid synthase (FAS) predictive strength in poorly differentiated early breast carcinomas

21 January 2018

1 reference

12 December 2020

Curcumin induces apoptosis in human non-small cell lung cancer NCI-H460 cells through ER stress and caspase cascade- and mitochondria-dependent pathways.

1 reference

12 December 2020

FAS expression inversely correlates with PTEN level in prostate cancer and a PI 3-kinase inhibitor synergizes with FAS siRNA to induce apoptosis

1 reference

12 December 2020

Synthesis and antitumor activity of an inhibitor of fatty acid synthase

1 reference

12 December 2020

Enzymes of the fatty acid synthesis pathway are highly expressed in in situ breast carcinoma

1 reference

12 December 2020

Inhibition of fatty acid synthesis delays disease progression in a xenograft model of ovarian cancer

1 reference

12 December 2020

Biodegradable microspheres of curcumin for treatment of inflammation.

1 reference

12 December 2020

Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions

1 reference

12 December 2020

Fatty acid synthase-catalyzed de novo fatty acid biosynthesis: from anabolic-energy-storage pathway in normal tissues to jack-of-all-trades in cancer cells.

1 reference

12 December 2020

Fatty acid synthase expression in melanoma

1 reference

12 December 2020

Gastrointestinal stromal tumours overexpress fatty acid synthase

1 reference

12 December 2020

Elevated expression of fatty acid synthase and fatty acid synthetic activity in colorectal neoplasia.

1 reference

12 December 2020

Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation

1 reference

12 December 2020

10.1007/S11523-013-0286-5

Identifiers

DOI

1 reference

9 September 2017

1 reference

PubMed ID

23821378